Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma

Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.

138 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma trial results

Completed

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

NCT04537715

Conditions
Adenoma, Advanced Malignancies, All Malignancies, +32 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details
Completed

Dose Individualization of Pemetrexed - IMPROVE-I

NCT03656549

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • Antoni van Leeuwenhoek Amsterdam, Netherlands
  • Catharina hospital Eindhoven, Netherlands
  • Maastricht University Medical centre Maastricht, Netherlands
View Trial Details
Completed

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

NCT02784171

Conditions
Adenoma, Mesothelioma, Neoplasms, +3 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
View all 57 locations
View Trial Details
Completed

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

NCT02899299

Conditions
Adenoma, Mesothelioma, Neoplasms, +3 more
Locations
  • Ucsf San Francisco, California, United States
  • Local Institution - 0014 New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Inst, Inc Tampa, Florida, United States
  • Local Institution - 0002 Chicago, Illinois, United States
View all 109 locations
View Trial Details
Completed

DENdritic Cell Immunotherapy for Mesothelioma

NCT03610360

Conditions
Adenoma, Mesothelioma, Neoplasms, +3 more
Locations
  • University Hospital Antwerp Antwerp, Belgium
  • Centre Hospitalier Régional Universitaire de Lille Lille, France
  • Universitá Politecnica delle Marche - Ospedali Riuniti di Ancona Ancona, Italy
  • Netherlands Cancer Institue Amsterdam, Netherlands
View Trial Details

Related conditions